Sierra Oncology, Inc. 4
4 · Sierra Oncology, Inc. · Filed May 30, 2017
Insider Transaction Report
Form 4
ESTES DANIEL
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-05-25+50,000→ 50,000 totalExercise: $1.20Exp: 2027-05-25→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Stock options were granted in connection with the reporting person's appointment to the issuer's board of directors on April 10, 2017.
- [F2]The option vests as to 8.333% of the total shares monthly, beginning on June 25, 2017, with 100% of the total shares vested and exercisable on May 25, 2018, subject to the reporting person's provision of service to the issuer on each vesting date.